Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodivers ...
Imagine a world where the majestic woolly mammoth roams the Arctic tundra once again, thousands of years after its extinction ...
Colossal Biosciences CEO and co-founder Ben Lamm gets the Jurassic Park comparison. When your company is trying to bring back ...
Woolly mammoth bones that have been on display at the Natural History Society of Maryland’s museum on Belair Road since last ...
Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...
The World Economic Forum predicts that biodiversity loss could cause a colossal decline in global GDP of $2.7 trillion ...
Nearly every night for the next three weeks, Manuel Oliver will step onstage at D.C.’s Woolly Mammoth Theatre, then travel ...
Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, ...
“But tomorrow it’ll be causing economic effects.” Perhaps known best for its efforts to bring back the woolly mammoth, Dallas-based Colossal’s core mission is preserving biodiversity ...
You know what they say, “Life finds a way.” A startup company is trying to raise money to bring back the woolly mammoth.